RBC Capital Downgrades Pliant Therapeutics (PLRX) to Sector Perform
Tweet
Share
E-mailGet Alerts PLRX Hot Sheet
Price: $1.10 --0%
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 19
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 19
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams downgraded Pliant Therapeutics (NASDAQ: PLRX) from Outperform to Sector Perform with a price target of $4.00 (from $45.00).
For an analyst ratings summary and ratings history on Pliant Therapeutics click here. For more ratings news on Pliant Therapeutics click here.
Shares of Pliant Therapeutics closed at $7.79 yesterday.
You May Also Be Interested In
- Nomura/Instinet Downgrades China Literature (772:HK) (CHLLF) to Neutral
- Citi Downgrades Lend Lease Group (LLC:AU) (LLESY) to Neutral
- Teijin Ltd (3401:JP) PT Raised to JPY1,860 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
